Amisulpride Patent Expiration

Amisulpride is Used for prevention and treatment of post-operative nausea and vomiting. It was first introduced by Acacia Pharma Ltd in its drug Barhemsys on Feb 26, 2020.


Amisulpride Patents

Given below is the list of patents protecting Amisulpride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Barhemsys US11357753 Rescue treatment of post operative nausea and vomiting Feb 09, 2038 Acacia
Barhemsys US9084765 Use of amisulpride as an anti-emetic Feb 26, 2034 Acacia
Barhemsys US10525033 Use of amisulpride as an anti-emetic Mar 10, 2031 Acacia
Barhemsys US9545426 Use of amisulpride as an anti-emetic Mar 10, 2031 Acacia
Barhemsys US9889118 Use of amisulpride as an anti-emetic Mar 10, 2031 Acacia



Amisulpride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List